Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of PH100 in Type 2 Diabetes Mellitus Patients with Recent Cardiovascular Complications
KCT0004471Phase 2Completed
- Sponsor
- Bota Bio
- Start
- Mar 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PH100 in type 2 diabetes mellitus (T2DM), cardiac morbidity, sponsored by Bota Bio. Started Mar 2016; status: completed.
02
Drugs
PH100
03
Conditions
type 2 diabetes mellitus (T2DM)cardiac morbidity
Beyond the preview
Go deeper on KCT0004471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004471.